cell culture
Choose 1 of 1 families

The Next Step Towards Scaling Up Your Cell Therapy

The field of cell therapy is transforming the way patients can be treated. Lonza Pharma & Biotech division helps drive innovative cell therapies to market. We provide a range of solutions from process development to commercial manufacturing. These include upstream products like cell culture media and downstream products like buffers and wash solutions.

Lonza appreciates the aspects related to bring therapies to market and has created the TheraPEAK™ Products to facilitate this process. These include higher quality controls, better environmental monitoring, additional product testing and comprehensive technical and regulatory support.

Lonza has been in the cell culture media market for over 50 years. This has resulted in a sequence of successful media formulations, including those used in commercial production of FDA approved drugs. Lonza is at the forefront of cutting edge technology to offer platform solutions to the cell therapy market. Lonza has a variety of formulations to assist customers with T-cell, mesenchymal stem cell (MSC) and induced pluripotent stem cell (iPSC) therapies.

 

Immuntherapy Knowledge Center